- Overview
-
Species
MouseStrain common name
Pdgfrb F7Full nomenclature
Pdgfrb F7/F7Genetic background
129S1/SvlmJDescription of model, including genes and any mutation(s):
Chronic pericyte deficiency - Platelet-derived growth factor receptor β mutant mice, PdgfrbF7/F7 (F7/F7), were generated by point mutations that disrupt the following residues and designated signal transduction pathways; residue 578 (Src), residue 715 (Grb2), residues 739 and 750 (PI3K), residue 770 (RasGAP), residue 1008 (SHP-2), by changing the tyrosine to phenylalanine, and residue 1020 (PLCγ), where tyrosine was mutated to isoleucine (Tallquist et al, PLoS Biol 2003). F7/F7 mice were maintained on a 129S1/SvlmJ background and were shown to express PDGFRβ in the brain exclusively in perivascular mural cells including pericytes, and not in neurons, astrocytes or endothelial cells (Bell et al, Neuron 2010; Winkler et al, Mol Neurodegener 2010).
Original publication of model
DOI: 10.1371/journal.pbio.0000052Breeding scheme
Het x HetType of model
Small vessel disease - Availability
-
Principal investigator
Axel MontagneInstitution
UK DRI at EdinburghNamed contact
Axel MontagneContact email
axel.montagne@ed.ac.ukSource of model
In-houseSupplier code
-MTA Holder and Issuing Organisation:
- - Study details
-
Sex
BothAge of model
2 weeks, 1-1.5 months, 3-4 months, 9-12 monthsDuration of Study
11 monthsDiet
Standard chowCage enrichment and housing
Group housingTypes of outcomes measured
Cell biology (i.e. protein-protein interactions)Neurobehaviour (i.e. sensory, motor, cognition)Omics (i.e transcriptomics, proteomics, metabolomics)Structural measure (i.e. IHC, EM, structural MRI)Vascular function (i.e. BBB integrity, CBF)Details of Outcomes Measured
Structure (IHC, EM, structural MRI), behaviour (nesting, burrowing, Y-maze, NOL, NOR, fear conditioning), Vascular function (MRI-derived BBB, CBF, endothelial function, and microbleeds), Cell biology (endothelium-pericyte-microglia tripartite interaction), Omics (scRNAseq endothelial cells and pericytes vs the rest)
Strengths of Model
- Chronic pericyte-deficiency not affecting vascular smooth muscle cells before 1 year of age
- Mimics the clinical findings supporting pericyte loss during normal ageing, which is accelerated in a context of dementiaLimitations of Model
- Small litters
Reference to published procedure
DOI: 10.1038/nm.4482
Image

Chronic pericyte deficiency
Small vessel disease